* Predictive Oncology Inc POAI.OQ POAI.O is expected
to show a
rise in quarterly revenue when it reports results on March 14
(estimated).
* The Eagan Minnesota-based company is expected to report
a
750.9% increase in revenue to $2.5 million from $293.79 thousand
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Predictive Oncology
Inc
is for a loss of 2 cents per share. For the same quarter last
year, the company reported a loss of 70 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Predictive
Oncology Inc is $5, above its last closing price of $0.94.
This summary was machine generated March 11 at 20:48 GMT. All
figures in US dollars unless otherwise stated